Hepatitis B latest mortality rate 100,000 population
Last updated on Thursday, 20 November 2025 at 03:12pm
Summary
- Topic
- Hepatitis-B
- Category
- headline
- API name
hepatitis-b_headline_deaths
Rationale
This metric shows the number of deaths from hepatitis B related end stage liver disease (ESLD) and/or hepatocellular carcinoma (HCC). Monitoring hepatitis B-related mortality helps to monitor the impacts of whether individuals living with hepatitis B are promptly diagnosed, engaged with care, and have access to treatment when eligible. The WHO mortality target to demonstrate hepatitis B elimination is 4 per 100,000 or fewer deaths related to hepatitis B each year.
Methodology
The upper bound links data from national mortality records where the cause of death is recorded as ESLD and/or HCC or hepatitis B is recorded to hospital admissions data where ESLD and/or HCC or hepatitis B are recorded and laboratory diagnosis data for hepatitis B to yield a maximum number of deaths attributable to hepatitis B related ESLD and/or HCC.
Rates are calculated per 100,000 population using Office for National Statistics (ONS) population estimates.
Caveats
Some deaths linked to hepatitis B may not be accurately recorded. The data is presented as an upper bound and the true number of deaths is expected to be lower than this. The lower bound is presented elsewhere on the dashboard.
Hepatitis B related end-stage liver disease is defined by codes or text entries for ascites, bleeding oesophageal varices, hepato-renal syndrome, hepatic encephalopathy, or hepatic failure.